Peer-Support Certification Program Bill
S.195 would task the Department of Mental Health with the creation a mental health peer support specialist certification program. It would also include a funding request for peer-operated respite models and community centers in subsequent budget proposals and would require that: (1) additional peer-operated respite centers and community centers should be developed with State Medicaid matching funds to provide necessary program capacity; and (2) viable proposals with demonstrable community support are advanced and the Agency finds that these proposals will reduce other State program costs.
VMS Position: Support
Status: Passed by the Senate, Advances to the House Human Services Committee
(Back to the top)
|
|
Mental Health Legislation Aimed at Preventing Emergency Department Wait Times
S.197 started as a bill to create a Coordinated Mental Health Crisis Response Working Group for the purpose of developing and articulating a predictable and coordinated system of response to mental health crises. After much testimony from VMS, community providers and the Department of Mental Health, the bill mophed in to a more comprehensive bill aimed at creating supports for school based mental health services. The bill will be on the Senate Floor for discussion the final week of March and now includes directing the Department of Mental Health in consultation with the Agency of Education, Agency of Human Services and the Department of Public Safety, to complete an inventory of the mental health crisis response on or before January 15, 2023. The inventory must be included in a mobile crisis needs assessment report. The bill would also provide supports to schools and educators by:
- Requiring AOE to provide statewide COVID-19 recovery supports to educators and school staff;
- Initiating grants to expand mental health and well-being services to youth; and
- Requiring a report from the Vermont Interagency Afterschool Youth Task Force.
VMS, AAPVT, VTAFP and VPA provided testimony on both of these bill – see full testimony here.
VMS Position: Support
Status: Passed by the Senate, Advances to the House Human Services Committee
(Back to the top)
|
|
Senate Makes Changes to the Patient End of Life Choices Law
S.74, amends Act 39, the Patient End of Life Choices law, and aims to make the process for Vermont patients to access medication to hasten their death less cumbersome. The bill has passed the Senate and has had an initial hearing in the House Human Services Committee. The bill would allow requests for the medication to hasten end of life to be made via telemedicine means and eliminate in-person requirements for oral requests and also aims to eliminate a 48-hr waiting period.
The bill also adds language that no physician, nurse, pharmacist, or anyone else would be subject to civil or criminal liability or professional disciplinary action for acting in good faith compliance with the provisions of this chapter.
VMS Position: Monitor
Status: Passed by the Senate, Advances to the House Human Services Committee
(Back to the top)
|
|
S. 239 Addresses Medicare Supplemental Health Insurance Policies
The Senate Committees on Health & Welfare and Finance took up the issue of enrollment in and coverage by Medicare supplemental insurance policies, especially exploring ways to extend or have additional enrollment periods in supplemental plans. The bill as now being considered by the full Senate would direct the Department of Financial Regulation (DFR) to convene a group of interested stakeholders to consider issues relating to the availability of, enrollment in, and use of supplemental coverage by individuals enrolled in Medicare or a Medicare Advantage plan. Among other topics, the group should examine the effects of annual or continuous open enrollment periods for Medicare supplemental coverage available in other states and options for enabling Vermont residents to enroll in Medicare supplemental coverage after their initial open enrollment period ends. A report would be due from DFR by January 15, 2023.
VMS Position: Monitor
Status: Passes the House, Advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
Bill to Add Hearing Aid Coverage to Large Group Plans Passes House
H.266, a bill that requires health plan coverage for hearing aids, has passed the House and had an initial hearing in the Senate Health and Welfare Committee. The bill codifies Vermont Medicaid’s current provision of coverage for hearing aids, aims to require coverage for hearing aids for the plan year starting January 1, 2024 for large group health insurance plans and requires the Department of Financial Regulation to report back on the process of hearing aids being approved by federal regulators as an essential health benefit to be included in Vermont's benchmark plan for the individual and small group markets. The legislature's proposal mimics Medicaid’s current benefit to provide coverage for an annual exam by an audiologist and one hearing aid for each ear every 36-months. Beginning in plan year 2023, the State Employee plan will include coverage for an annual exam by an audiologist and one hearing aid per ear every 60-months.
VMS Position: Support
Status: Passes the House, Advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
Medicaid Bill Includes Prescription Drug Prior Authorization Report
H.279, is a miscellaneous Department of Vermont Health Access bill, which includes a provision allowing the Department, in the event that Congress extends the federal premium tax credits, to require insurance carriers to make all accommodations for eligible Vermont households to receive the assistance within the 2023 plan years. The bill also requires the Commissioner of DVHA to report on the operation of Vermont’s pharmaceutical assistance programs for the most recent State fiscal year and the Department’s use of prior authorizations for prescription drugs. The bill passed the House and has been referred to the Senate Health and Welfare Committee.
VMS Position: Support
Status: Passed the House, advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
Pharmacy Benefit Manager Regulation Bill Passes House
H.353, a bill that aims to better regulate pharmacy benefit managers (PBMs) that contract with Vermont insurers and other entities, has passed the House and advances to the Senate. The Vermont Independent Pharmacists urged support for this bill and said PBMs are paying less than cost. They also cited severe access issues for consumers in getting their medication. There are only two compounding pharmacies in Vermont and there are 17 independent pharmacies in the state, which is down from 42 ten years ago. There are roughly 140 total pharmacies in the State. This bill prohibits any PBMs from requiring a beneficiary purchasing a covered prescription drug to pay an amount greater than:
(A) the cost-sharing amount under the terms of the health benefit plan;
(B) the maximum allowable cost for the drug; or
(C) the amount the covered person would pay for the drug, after application of any known discounts, if the covered person were paying the cash price.
The bill also requires a health insurer or PBM to allow a beneficiary to fill a prescription at the in-network pharmacy of the beneficiary’s choice and cannot impose differential cost-sharing requirements based on the choice of pharmacy or otherwise promote the use of one pharmacy over another. The Department of Financial Regulation must analyze and report back in January, 2023 on potential regulation of pharmacy benefit management and its effects on Vermonters, on pharmacies and pharmacists, and on health insurance in this State.
VMS Position: Support
Status: Passed the House, advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
Bill to Prohibit Discrimination Based on Genetic Information Passes Senate
S.247, a bill that prohibit discrimination based on one's genetic information, has passed the Senate and has been referred to the House Health Care Committee. This bill aims to prohibit any health insurance or life insurance plans from conditioning coverage on the basis of a beneficiary's genetic information that indicates a potential genetic condition. The bill also prohibits using genetic information or the results of genetic testing as a condition of insurance rates or the renewal of insurance and includes this practice as "unfair discrimination."
VMS Position: Support
Status: Passed the Senate, Advances to the House Health Care Committee.
(Back to the top)
|
|
A Bill Seeking to Delay Medicaid Prior Auth Advances
H.728 (p.78), a bill aimed at providing opioid overdose response services, passed the House floor and advances to the Senate. This bill was a House Human Services Committee bill that would have originally delayed prior authorizations (PAs) for medication-assisted-treatment (MAT) for 60 days, in part because Committee members heard that Medicaid’s PA process for approving mono-buprenorphine products is onerous and presents an unnecessary barrier to treatment. The Department of Vermont Health Access (DVHA) testified that removing all PAs would result in an estimated fiscal impact for the Vermont Medicaid program between $16.97 million and $35 million. These estimates were based on providers moving to treatment formulas not on Medicaid’s preferred drug list and of higher doses than 16 mg for Spoke patients. Before the bill went to the House, the Committee and DVHA landed on a compromise that requires Medicaid to cover at least one medication in each therapeutic class for methadone, buprenorphine, and naltrexone as listed on Medicaid’s preferred drug list without requiring prior authorization, after they are approved by the Drug Utilization Review Board (DURB).
The bill also requires DVHA to analyze and provide recommendations on MAT and prior authorizations regarding:
- Quantity limits and preferred medications for buprenorphine products;
- The feasibility and costs for adding mono-buprenorphine products as preferred medications and the current process for verifying adverse effects;
- How other states’ Medicaid programs address prior authorization for medication-assisted treatment, including the 60-day deferral of prior authorization implemented by Oregon’s Medicaid program;
- The appropriateness and feasibility of removing annual renewal of prior authorization;
- The appropriateness of creating parity between hub-and-spoke providers with regard to medication-assisted treatment quantity limits; and
- Creating an automatic emergency 72-hour pharmacy override default.
The Department will need to report their findings to the DURB and to the legislature by January 15, 2023. The bill also:
- Expands the locations in which an organized community-based, peer-operated needle exchange programs can operate;
- Establishes the Overdose Prevention Site Working Group who will examine the feasibility of implementing safe injection sites across the state;
- Appropriates $450,000 for three pilot programs to provide mobile medication-assisted treatment services.
VMS Position: Support
Status: Passed the House, advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
Professional Regulation/Scope of Practice
|
|
|
S.158, A Bill to Allow Optometrists to Perform Eye Surgery Will Not Move Forward this Year
The Senate Government Operations Committee took testimony for several days on S.158, a bill that would have allowed optometrists to perform eye surgery using scalpels, injections and lasers with minimal training. While modifications to the bill were discussed, the Senate Government Operations Committee ultimately decided to send this issue back to the Office of Professional Regulation to go through a statutory assessment for scope of practice expansions. The Committee noted that they had "hit a brick wall" without a clear path forward and did not have enough support from the full Senate to move a proposal forward. Thank you to all of our members for the outreach and communications to legislators on this bill! It made a difference!
The new OPR assessment requires the profession asking for a scope expansion to provide a number of categories of information prior to the OPR undertaking the study. This process will take place next summer/fall and will include stakeholder engagement and public hearings. The final report will be due back to the legislature in November 2023 for review/possible action in the 2024 legislative session (starting in January). VMS and the Vermont Ophthalmological Society will be engaged in the process and keep you updated.
Vermont Ophthalmolgoical Society and VMS members provided extensive testimony on this bill which can be viewed here:
Jessie McNally, M.D.
Brian Kim, M.D.
Amy Gregory, M.D.
VMS Position: Oppose
Status: Died in the Senate Government Operations Committee.
(Back to the top)
|
|
Constitutional Amendment to Support the Fundamental Right to Reproductive Liberty
Proposition 5, a constitutional amendment that creates a right to reproductive liberty, passed the House by a vote of 107- 41 in its final legislative stage earlier this session. It will now go before the voters of Vermont as a referendum on the ballot in November 2022. The VMS has taken an active role in advocating for this landmark proposal over the last four years as the process to add an article to Vermont’s constitution happens over two legislative bienniums. What would be known as "Article 22" states: Article 22. [Personal reproductive liberty] That an individual’s right to personal reproductive autonomy is central to the liberty and dignity to determine one’s own life course and shall not be denied or infringed unless justified by a compelling State interest achieved by the least restrictive means." The language for Proposition 5 was finalized in 2019 by the Senate Health and Welfare Committee and had to pass both chambers several times with no further amendments to the language. With state abortion rights being obliterated across the nation, the VMS expects the campaign leading up to the referendum to be expensive and influnced by national political agendas. The VMS will continue to advocate for medical care to be a decision between a patient and their clinician.
VMS Position: Support
Status: Passed, On November, 2022 as referendum.
(Back to the top)
|
|
Firearm Safety Legislation Takes Multiple Paths this Session
S.30 passed the House and Senate in February and was sent to the Governor. This bill would prohibit firearms in hospitals and close the “Charleston Loophole” by prohibiting a gun sale if a federal background check does not come back in a timely manner. The Governor vetoed the bill, citing the broadness of the expansion of the time allowed for a federal background check to be completed from 3 days (current law) to unlimited in the bill. The Governor stated he was open to revisiting the change if law if there was a discrete period of time for background checks to come back. Born from that veto, S.4 was introduced, which prohibits firearms in hospitals and closes the “Charleston Loophole,” but increases the length of time the federal background check system has to respond to 7 days instead of 3. S.4 was signed by Governor Scott on March 25th.
VMS Position: Support
Status: Signed by the Governor, Effective July 1, 2022.
(Back to the top)
|
|
S. 90 Would Establish an Amyotrophic Lateral Sclerosis Registry
S. 90 has passed the Senate and advances to the House Health Care Committee. The bill directs the Commissioner of Health to establish a uniform statewide population-based amyotrophic lateral sclerosis (ALS) registry for the purpose of determining the incidence of ALS in Vermont. The bill would require all cases of ALS diagnosed or treated in the State to be reported to the Department of Health within 180 days of diagnosis. The Department of Health testified that a registry may not provide the type of data many proponents of the bill are seeking, especially given the small number of cases diagnosed each year in Vermont, and that the costs to establishing the registry (financial, logistical and regulatory) are significant. Should the bill pass the Senate and be taken up in the House, VMS will continue to monitor the progress and work to ensure minimum administrative burdens of a registry.
VMS Position: Monitor
Status: Passed the Senate, Advances to the House Health Care Committee.
(Back to the top)
|
|
S.206, Planning and Support for Alzheimer’s Disease
S. 206 is an act related to planning and support for individuals and families impacted by Alzheimer’s Disease and related disorders. The bill passed the Senate on March 11th and has now been referred to the House Committee on Human Services. The bill as passed the Senate:
- Charges the State’s Commission on Alzheimer’s Disease and Related Disorders to advise and provide comments to the Departments of Health and of Disabilities, Aging, and Independent Living (DAIL) regarding the development of the State Plan on Aging as it relates to Alzheimer’s disease and dementia;
- Requires DAIL’s State Plan on Aging to address the needs of individuals with Alzheimer’s disease and related disorders and to include as an addendum the State Plan on Alzheimer’s Disease and Healthy Aging;
- Directs the Departments of Health and DAIL to jointly develop and maintain easily accessible electronic, print, and in-person public education materials and programs on Alzheimer’s disease and related disorders that shall serve as a resource for patients, families, caregivers, and health care providers;
- Directs the Chair of the Commission on Alzheimer’s Disease and Related Disorders to appoint at least three members of the Commission to serve as a work group for the purpose of making recommendations to achieve a dementia-capable workforce and promote and expand educational opportunities for health care and human services providers.
VMS testified in favor of ongoing efforts to improve dementia care in Vermont, including efforts to improve and increase clinical education but expressed concern with several sections of the bill as introduced, which would have mandated continuing medical education as well as mandated certain disclosures to family members of those diagnosed with Alzheimer’s Disease. These sections were significantly modified and addressed VMS’ concerns.
VMS Position: Monitor
Status: Passed the Senate, Advances to the House Human Services Committee.
(Back to the top)
|
|
Cannabis Legislation Passes Without the Lifting of THC Potency Limits
H.548, this session’s Misc. Cannabis bill, has passed the House and has been assigned to the Senate Judiciary Committee. Originally this bill had included a provision that would have removed a 60 percent THC potency limit in solid concentrates that is currently in Vermont statute. The Cannabis Control Board (CCB) asked for the removal, arguing that by removing the potency limits the State would successfully “bring the illicit market into the regulated cannabis market.” The VMS adopted a policy in the Fall of 2021 that cannabis use, especially with potency greater than 15% THC, is associated with increased urgent and emergency department psychiatric visits, mental health disorders, respiratory distress, cannabis hyperemesis syndrome (uncontrollable vomiting) and poisonings. The bill, which was originally heard in the House Judiciary Committee, was moved to the House Government Operations Committee after VMS argued that removing the potency limits was not a “technical change” as the CCB put forth. The Government Operations Committee, having been the Committee that led the passage of Act 54, defended the potency limits they originally put into place and passed H.548 with the limits still in place. Committee members said, “we need to slow this process down.” The VMS Policy team will continue to defend the THC potency limits as the bill advances in the Senate. Please read the VMS testimony here.
VMS Position: Oppose Increasing Potency Caps
Status: Passed the House, in Senate Judiciary Committee
(Back to the top)
|
|
H. 628 Eases Ability to Modify Gender Identity on Birth Certificates
H. 628 directs the Department of Health to adopt rules to implement, administer and/or enforce a simple process by which an individual may amend the marker on a birth certificate to reflect the individual’s gender identity, including a third nonbinary marker. Current Vermont law regarding changing gender on a birth certificate requires the individual to submit an affidavit of a physician that an individual has undergone gender transition. The bill has passed the House and Senate.
VMS Position: Support
Status: Passed the House and Senate, Advances to the Governor's Desk.
(Back to the top)
|
|
Bill to Close Child Marriage Loopholes Fails to Advance
H.631, a bill seeking to end child marriage, was taken up for debate early in the session in the House Judiciary Committee, yet failed to advance due to concerns regarding underlying emancipation law. The VMS supported this proposal as evidence shows that child marriage before 18, the age of majority, impacts Vermont adolescents’ health, education and economic opportunities, and increases risks of experiencing violence and poverty. The VMS provided this testimony. The Committee has expressed a willingness to take up this proposal in legislative session 2023 when other laws that impact child autonomy and emancipation can be fully vetted.
VMS Position: Support
Status: Died in House Judiciary.
(Back to the top)
|
|
Opioid Settlement Advisory Committee Legislation
H.711, a bill that creates an Opioid Settlement Advisory Committee, passed the House and has advanced to the Senate Health and Welfare Committee. The Advisory Committee will be housed in the Vermont Department of Health and will help guide the distribution of the estimated $38 million that will be coming to Vermont from the Purdue-Sackler settlement reported in VPR. As recommended by VMS, the Advisory Committee includes a primary care prescriber with experience providing MAT within the Blueprint for Health hub and spoke model. The Advisory Committee will consult with individuals with direct lived experience of opioid use disorder, frontline support professionals, the Substance Misuse Advisory Council, and other stakeholders to identify spending priorities related to opioid use disorder prevention, intervention, treatment, recovery services and harm reduction strategies for the purpose of providing recommendations to the Governor, the Department of Health, and the General Assembly on prioritizing spending from the Opioid Abatement Special Fund.
VMS Position: Support
Status: Passed the House, advances to the Senate Health and Welfare Committee.
(Back to the top)
|
|
|
|
|